William Bender
Overview
Dr. William Bender grew up in New England and completed his undergraduate education at Middlebury College where he majored in history. He then went on to receive his Masters in Public Health from the Center for Evaluative Clinical Sciences (now the Dartmouth Institute for Health Policy and Clinical Practice) at the Geisel School of Medicine at Dartmouth College. He subsequently obtained his medical degree from the Georgetown University School of Medicine in 2009 and then stayed at Georgetown to complete his residency in internal medicine in 2012.
In 2015, he completed his fellowship training in Pulmonary and Critical Care Medicine at New York University where he worked under the direction of Dr. Laura Evans examining the delivery of bundled sepsis therapy to inpatients that develop severe sepsis and septic shock along with the delineation of an appropriate time zero for this patient population. He was recruited to join the faculty at Emory in 2015 as an assistant professor of medicine.
Research
Dr. Benders research focus is centered on quality improvement within the field of critical care medicine. He has a specific interest in the processes and barriers associated with the implementation of evidence into practice particularly as they relate to the delivery of care for patients with sepsis and acute respiratory distress syndrome (ARDS). He also has an interest in medical education and teaching students, residents and fellows as well as exploring the changing style of medical education, predominantly as it relates to the rise of online educational resources.
Outside interests
When he is not working, Dr. Bender enjoys spending time his family, cooking, skiing, spending time outdoors and rooting for all professional Boston sports teams.
Academic Appointment
- Assistant Professor of Medicine, Emory University School of Medicine
Education
Degrees
- MD from Georgetown University School of Medicine
- MA from Boston University
- MPH from Dartmouth College
- BA from Middlebury College
- Residency from Georgetown University School of Medicine
Research
Publications
-
Early trajectories of virological and immunological biomarkers and clinical outcomes in patients admitted to hospital for COVID-19: an international, prospective cohort study.
Lancet Microbe Volume: 5 Page(s): e559 - e569
06/01/2024 Authors: Jensen TO; Murray TA; Grandits GA; Jain MK; Grund B; Shaw-Saliba K; Matthay MA; Abassi M; Ardelt M; Baker JV -
Vaccine Effectiveness Against Influenza A-Associated Hospitalization, Organ Failure, and Death: United States, 2022-2023.
Clin Infect Dis Volume: 78 Page(s): 1056 - 1064
04/10/2024 Authors: Lewis NM; Zhu Y; Peltan ID; Gaglani M; McNeal T; Ghamande S; Steingrub JS; Shapiro NI; Duggal A; Bender WS -
Severity of Respiratory Syncytial Virus vs COVID-19 and Influenza Among Hospitalized US Adults.
JAMA Netw Open Volume: 7 Page(s): e244954
04/01/2024 Authors: Surie D; Yuengling KA; DeCuir J; Zhu Y; Lauring AS; Gaglani M; Ghamande S; Peltan ID; Brown SM; Ginde AA -
Disease Severity of Respiratory Syncytial Virus Compared with COVID-19 and Influenza Among Hospitalized Adults Aged 60 Years - IVY Network, 20 U.S. States, February 2022-May 2023.
MMWR Morb Mortal Wkly Rep Volume: 72 Page(s): 1083 - 1088
10/06/2023 Authors: Surie D; Yuengling KA; DeCuir J; Zhu Y; Gaglani M; Ginde AA; Talbot HK; Casey JD; Mohr NM; Ghamande S -
Intravenous aviptadil and remdesivir for treatment of COVID-19-associated hypoxaemic respiratory failure in the USA (TESICO): a randomised, placebo-controlled trial.
Lancet Respir Med Volume: 11 Page(s): 791 - 803
09/01/2023 Authors: Brown SM; Barkauskas CE; Grund B; Sharma S; Phillips AN; Leither L; Peltan ID; Lanspa M; Gilstrap DL; Mourad A -
Effectiveness of Monovalent mRNA COVID-19 Vaccination in Preventing COVID-19-Associated Invasive Mechanical Ventilation and Death Among Immunocompetent Adults During the Omicron Variant Period - IVY Network, 19 U.S. States, February 1, 2022-January 31, 2023.
MMWR Morb Mortal Wkly Rep Volume: 72 Page(s): 463 - 468
04/28/2023 Authors: DeCuir J; Surie D; Zhu Y; Gaglani M; Ginde AA; Douin DJ; Talbot HK; Casey JD; Mohr NM; McNeal T -
Absolute and Relative Vaccine Effectiveness of Primary and Booster Series of COVID-19 Vaccines (mRNA and Adenovirus Vector) Against COVID-19 Hospitalizations in the United States, December 2021-April 2022.
Open Forum Infect Dis Volume: 10 Page(s): ofac698
01/01/2023 Authors: Lewis NM; Murray N; Adams K; Surie D; Gaglani M; Ginde AA; McNeal T; Ghamande S; Douin DJ; Talbot HK -
Early Estimates of Bivalent mRNA Vaccine Effectiveness in Preventing COVID-19-Associated Hospitalization Among Immunocompetent Adults Aged 65 Years - IVY Network, 18 States, September 8-November 30, 2022.
MMWR Morb Mortal Wkly Rep Volume: 71 Page(s): 1625 - 1630
12/30/2022 Authors: Surie D; DeCuir J; Zhu Y; Gaglani M; Ginde AA; Douin DJ; Talbot HK; Casey JD; Mohr NM; Zepeski A -
Effectiveness of Monovalent mRNA Vaccines Against COVID-19-Associated Hospitalization Among Immunocompetent Adults During BA.1/BA.2 and BA.4/BA.5 Predominant Periods of SARS-CoV-2 Omicron Variant in the United States - IVY Network, 18 States, December 26, 2021-August 31, 2022.
MMWR Morb Mortal Wkly Rep Volume: 71 Page(s): 1327 - 1334
10/21/2022 Authors: Surie D; Bonnell L; Adams K; Gaglani M; Ginde AA; Douin DJ; Talbot HK; Casey JD; Mohr NM; Zepeski A -
Efficacy and safety of two neutralising monoclonal antibody therapies, sotrovimab and BRII-196 plus BRII-198, for adults hospitalised with COVID-19 (TICO): a randomised controlled trial.
Lancet Infect Dis Volume: 22 Page(s): 622 - 635
05/01/2022 Authors: ACTIV-3/Therapeutics for Inpatients with COVID-19 (TICO) Study Group